RESÚMENES OCTUBRE 2005

.

Other Neuropsychiatric Disorders & General Information

(Requiere estar conectado a internet. Haga un click en la información del journal)

 

Atomoxetine and stroop task performance in adult attention-deficit/hyperactivity disorder
Faraone SV, Biederman J, Spencer T, Michelson D, Adler L, Reimherr F, Seidman L

J Child Adolesc Psychopharmacol. 2005 Aug;15(4):664-70 

Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial
Stearns V, Slack R, Greep N, Henry-Tilman R, Osborne M, Bunnell C, Ullmer L, Gallagher A, Cullen J, Gehan E, Hayes DF, Isaacs C

J Clin Oncol. 2005 Oct 1;23(28):6919-30

 

Disentangling Deficits in Adults With Attention-Deficit/Hyperactivity Disorder

Evelijne M. Bekker, Carin C.E. Overtoom, J.J. Sandra Kooij, Jan K. Buitelaar, Marinus N. Verbaten, J. Leon Kenemans

Arch Gen Psychiatry. 2005;62:1129-1136

 

Association Between Smoking and Attention-Deficit/Hyperactivity Disorder Symptoms in a Population-Based Sample of Young Adults

Scott H. Kollins, F. Joseph McClernon, Bernard F. Fuemmeler

Arch Gen Psychiatry. 2005;62:1142-1147

 

The Prevalence of DSM-IV Personality Disorders in Psychiatric Outpatients

Mark Zimmerman, Louis Rothschild, and Iwona Chelminski

Am J Psychiatry 162:1911-1918, October 2005

Industry Sponsorship and Financial Conflict of Interest in the Reporting of Clinical Trials in Psychiatry

Roy H. Perlis, Clifford S. Perlis, Yelena Wu, Cindy Hwang, Megan Joseph, and Andrew A. Nierenberg

Am J Psychiatry 162:1957-1960, October 2005

Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring
Staner L, Ertle S, Boeijinga P, Rinaudo G, Arnal MA, Muzet A, Luthringer R

Psychopharmacology (Berl). 2005 Oct;181(4):790-8. Epub 2005 Sep 29

 

Can an inert sleeping pill affect sleep? Effects on polysomnographic, behavioral and subjective measures
Fratello F, Curcio G, Ferrara M, Marzano C, Couyoumdjian A, Petrillo G, Bertini M, De Gennaro L

Psychopharmacology (Berl). 2005 Oct;181(4):761-70. Epub 2005 Sep 29

Psychosis in Parkinson’s disease

B R Thanvi, T C N Lo and D P Harsh

Postgraduate Medical Journal 2005;81:644-646

 

Daily High Doses of Fluoxetine for Weight Loss and Improvement in Lifestyle before Bariatric Surgery
Dolfing JG, Wolffenbuttel BH, Ten Hoor-Aukema NM, Schweitzer DH

Obes Surg. 2005 Sep;15(8):1185-91

 

Efficacy of atomoxetine in adult attention-Deficit/Hyperactivity Disorder: a drug-placebo response curve analysis
Stephen V Faraone, Joseph Biederman, Thomas Spencer, David Michelson, Lenard Adler, Fred Reimherr and Stephen J Glatt
Behavioral and Brain Functions 2005, 1:16; 3 October 2005

 

Evaluation of risperidone in the treatment of behavioral and psychological symptoms and sleep disturbances associated with dementia
Duran JC, Greenspan A, Diago JI, Gallego R, Martinez G

Int Psychogeriatr. 2005 Oct 5;:1-14 [Epub ahead of print]

 

Suicide in borderline personality disorder: A meta-analysis

Maurizio Pompili, Paolo Girardi, Amedeo Ruberto, Roberto Tatarelli

Nordic Journal of Psychiatry. Volume 59, Number 5 / September 2005: 319 - 324

 

Delusions and Hallucinations Are Associated With Worse Outcome in Alzheimer Disease

Nikolaos Scarmeas, Jason Brandt, Marilyn Albert, Georgios Hadjigeorgiou, Alexandros Papadimitriou, Bruno Dubois, Maria Sarazin, Davangere Devanand, Lawrence Honig, Karen Marder, Karen Bell, Domonick Wegesin, Deborah Blacker, Yaakov Stern

Arch Neurol. 2005;62:1601-1608

 

Open Trial of Pindolol in the Treatment of Fibromyalgia

Patrick B Wood, Anita S Kablinger, Gloria S Caldito

Annals of Pharmacotherapy, 11 October 2005

 

Open-Label Study of Atypical Neuroleptic Quetiapine for Treatment of Borderline Personality Disorder: Impulsivity as Main Target

Evens Villeneuve, and Sophie Lemelin

J Clin Psychiatry 2005;66:1298-1303

 

Psychiatric Complications in Parkinson Disease

Daniel Weintraub, and Matthew B. Stern

Am J Geriatr Psychiatry 13:844-851, October 2005

The Role of Medical Comorbidity in Outcome of Major Depression in Primary Care. The PROSPECT Study

Hillary R. Bogner, Mark S. Cary, Martha L. Bruce, Charles F. Reynolds III, Benoit Mulsant, Thomas Ten Have, and George S. Alexopoulos

Am J Geriatr Psychiatry 13:861-868, October 2005

Decreased density of peripheral benzodiazepine receptors in psychiatric patients after a suicide attempt

Donatella Marazziti, Bernardo Dell'Osso, Stefano Baroni, Irene Masala, Elena Di Nasso, Gino Giannaccini and Luciano Conti

Life Sciences. Volume 77, Issue 26, 12 November 2005, Pages 3268-3275

 

Dementia and Alzheimer's Disease in Community-Dwelling Elders Taking Vitamin C and/or Vitamin E

Gerda G Fillenbaum, Maragatha N Kuchibhatla, Joseph T Hanlon, Margaret B Artz, Carl F Pieper, Kenneth E Schmader, Maurice W Dysken, Shelly L Gray

Annals Pharmacother; 14 October 2005

 

Vitamin C and Vitamin E for Alzheimer's Disease

Lisa A Boothby, Paul L Doering

Annals Pharmacother. 14 October 2005

 

 

Childhood adversities as risk factors for adult mental disorders. Results from the Health 2000 study

Sami Pirkola, Erkki Isometsä, Hillevi Aro, Laura Kestilä, Juha Hämäläinen, Juha Veijola, Olli Kiviruusu and Jouko Lönnqvist

Social Psychiatry and Psychiatric Epidemiology 2005; Volume 40, Number 10: 769 - 777

 

 

Predicting aftercare in psychiatric emergencies

Ronny Bruffaerts, Marc Sabbe and Koen Demyttenaere

Social Psychiatry and Psychiatric Epidemiology 2005; Volume 40, Number 10: 829 - 834

 

 

Recommendations of mental health professionals and the general population on how to treat mental disorders

Christoph Lauber, Carlos Nordt and Wulf Rössler

Social Psychiatry and Psychiatric Epidemiology 2005; Volume 40, Number 10: 835 - 843

 

Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease

Suvi Rovio,   Ingemar Kåreholt,   Eeva-Liisa Helkala,   Matti Viitanen,   Bengt Winblad,   Jaakko Tuomilehto,   Hilkka Soininen,   Aulikki Nissinen  and   Miia Kivipelto

Lancet Neurology 2005; 4:705-711

 

Sequential combinations of drug and cognitive behavioral therapy for chronic insomnia: An exploratory study

Annie Vallières, Charles M. Morin and Bernard Guay

Behaviour Research and Therapy. Volume 43, Issue 12, December 2005, Pages 1611-1630

 

Risk of Death With Atypical Antipsychotic Drug Treatment for Dementia. Meta-analysis of Randomized Placebo-Controlled Trials

Lon S. Schneider, Karen S. Dagerman, Philip Insel

JAMA. 2005;294:1934-1943

 

Attention Deficit Hyperactivity Disorder: manifestation in adulthood

Cynthia A. Riccio, Monica Wolfe, Brandon Davis, Cassandra Romine, Carrie George and Donghyung Lee

Archives of Clinical Neuropsychology. Volume 20, Issue 2, March 2005, Pages 249-269

 

Normal attention orienting but abnormal stimulus alerting and conflict effect in combined subtype of ADHD

Brandon G. Oberlin, James L. Alford and Richard T. Marrocco

Behavioural Brain Research. Volume 165, Issue 1, 30 November 2005, Pages 1-11

 

 

Artificial cranial deformation in newborns in the pre-Columbian Andes

Edgardo Schijman

Child's Nervous System 2005; Volume 21, Number 11: 945 - 950

 

Do depression symptoms predict seizure frequency—or vice versa?

Ajay Thapar, Martin Roland and Gordon Harold

Journal of Psychosomatic Research. Volume 59, Issue 5, November 2005, Pages 269-274

 

Is homeopathy a clinically valuable approach?

Edzard Ernst

Trends in Pharmacological Sciences. Volume 26, Issue 11, November 2005, Pages 547-548

 

Suicide Prevention Strategies. A Systematic Review

J. John Mann, Alan Apter, Jose Bertolote, Annette Beautrais, Dianne Currier, Ann Haas, Ulrich Hegerl, Jouko Lonnqvist, Kevin Malone, Andrej Marusic, Lars Mehlum, George Patton, Michael Phillips, Wolfgang Rutz, Zoltan Rihmer, Armin Schmidtke, David Shaffer, Morton Silverman, Yoshitomo Takahashi, Airi Varnik, Danuta Wasserman, Paul Yip, Herbert Hendin

JAMA. 2005;294:2064-2074

 

The Patents-Based Pharmaceutical Development Process. Rationale, Problems, and Potential Reforms

John H. Barton, Ezekiel J. Emanuel

JAMA. 2005;294:2075-2082

 

Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia

Deborah Layton, Scott Harris, Lynda V. Wilton, Saad A. W. Shakir

Journal of Psychopharmacology, Vol. 19, No. 5, 473-482 (2005)

The Metrics of the Physician Brain Drain

Fitzhugh Mullan

NEJM. Volume 353:1810-1818; October 27, 2005; Number 17

 

Olanzapine versus Haloperidol in the Treatment of Agitation in Elderly Patients with Dementia: Results of a Randomized Controlled Double-Blind Trial
Verhey FR, Verkaaik M, Lousberg R

Dement Geriatr Cogn Disord. 2005 Oct 21;21(1):1-8 [Epub ahead of print]

 

Systematic review of misdiagnosis of conversion symptoms and "hysteria"

Jon Stone, Roger Smyth, Alan Carson, Steff Lewis, Robin Prescott, Charles Warlow, Michael Sharpe

BMJ  2005;331:989 (29 October)

 

Olanzapine does not enhance cognition in non-agitated and non-psychotic patients with mild to moderate Alzheimer's dementia
Kennedy J, Deberdt W, Siegal A, Micca J, Degenhardt E, Ahl J, Meyers A, Kaiser C, Baker RW

Int J Geriatr Psychiatry. 2005 Oct 26;20(11):1020-1027 [Epub ahead of print]

.

Regresar a RESÚMENES OCTUBRE 2005